IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
116 eligible patients with confirmed non-metastatic colorectal adenocarcinoma and anemia will
be randomized to receive either oral ferrous sulphate (control) or intravenous ferric
carboxymaltose (intervention).
It is hypothesized that intravenous iron supplementation is more efficacious than oral iron
therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Collaborator:
National Institute for Health Research, United Kingdom